Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effect of the AI500™ SINGLE-DOSE GEL Medical Device in Patients With Reduced Knee Function: a Post-market Confirmatory Interventional, Single Arm Clinical Investigation

NCT05886608 is registered in ClinicalTrials.gov with Contrad Swiss SA as lead sponsor.

NCT NCT05886608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05886608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effect of the AI500™ SINGLE-DOSE GEL Medical Device in Patients With Reduced Knee Function: a Post-market Confirmatory Interventional, Single Arm Clinical Investigation
Lead sponsor
Contrad Swiss SA
Phase
Not applicable
Overall status
Completed
Start date
August 30, 2022
Completion date
March 16, 2023
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

knee arthritis, knee injuries, knee osteoarthritis, knee pain swelling, pain, acute, pain, chronic